Safety and efficacy of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases

被引：1
|
作者：
Novello, S. [1 ]
Camps, C. [2 ]
Grossi, F. [3 ]
Mazieres, J. [4 ]
Abrey, L. [5 ]
Fain, J. [6 ]
Patyna, S. [7 ]
Selaru, P. [7 ]
Chao, R. [7 ]
Scagliotti, G. [1 ]
机构：
[1] Univ Turin, Thorac Oncol Unit, Turin, Italy
[2] Univ Gen Hosp Valencia, Valencia, Spain
[3] Natl Inst Canc Res, Genoa, Italy
[4] Hop Larrey, Unite Cancerol Cervico Thorac, Toulouse, France
[5] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[6] Texas Oncol, Hematol Oncol, Austin, TX USA
[7] Pfizer Oncol, Dev, La Jolla, CA USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71866-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [21] The risk factors for brain metastases in patients with non-small cell lung cancer
    Lim, Jun Hyeok
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [22] Multimodality management of non-small cell lung cancer patients with brain metastases
    Ricciardi, Serena
    de Marinis, Filippo
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 86 - 93
  • [23] Treatment options for brain metastases in patients with non-small cell lung cancer
    Sadaf Taimur
    Martin J. Edelman
    Current Treatment Options in Oncology, 2003, 4 (1) : 89 - 95
  • [24] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [25] The management of brain metastases in non-small cell lung cancer
    Owen, Scott
    Souhami, Luis
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [26] Safety and Efficacy of Combining Sunitinib with Bevacizumab plus Paclitaxel/Carboplatin in Non-small Cell Lung Cancer
    Socinski, Mark A.
    Scappaticci, Frank A.
    Samant, Meghna
    Kolb, Margaret M.
    Kozloff, Mark F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 354 - 360
  • [27] Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases
    Gettinger, S. N.
    Bazhenova, L.
    Salgia, R.
    Langer, C. J.
    Gold, K. A.
    Rosell, R.
    Shaw, A. T.
    Weiss, G. J.
    Narasimhan, N. I.
    Dorer, D. J.
    Rivera, V. M.
    Clackson, T.
    Haluska, F. G.
    Camidge, D. R.
    LUNG CANCER, 2015, 87 : S32 - S32
  • [28] Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
    Galli, Giulia
    De Toma, Alessandro
    Pagani, Filippo
    Randon, Giovanni
    Trevisan, Benedetta
    Prelaj, Arsela
    Ferrara, Roberto
    Proto, Claudia
    Signorelli, Diego
    Ganzinelli, Monica
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina Chiara
    Lo Russo, Giuseppe
    LUNG CANCER, 2019, 137 : 38 - 42
  • [29] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
    Zhong, Yuejiao
    Wei, Qiang
    Lu, You
    Tang, Xiuliang
    Wang, Zhongqiu
    Chen, Lingxiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6016 - 6022
  • [30] Efficacy and Safety of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer
    Galli, G.
    De Toma, A.
    Pagani, F.
    Randon, G.
    Trevisan, B.
    Prelaj, A.
    Ferrara, R.
    Proto, C.
    Signorelli, D.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S454 - S454
12345